Elanco Animal Health announced it has closed its acquisition of AHV International, a Dutch innovator in farm animal health.

The acquisition is said to offer dairy producers an expanded portfolio of products to support transition cow health, well-being and improve productivity.  

Executive vice-president of Elanco International, Dr. Ramiro M. Cabral said: “The AHV addition is a strategic fit for Elanco by providing innovative tools for producers and veterinarians to improve the well-being of dairy cows.

"AHV's portfolio meaningfully expands our solutions for sustainability, animal welfare and transition cow health, as well as for retail packaged goods.

"Together with our dedicated scientific and technical Elanco team, the integration will unite the strengths of both organisations to deliver a comprehensive solution portfolio for our customers."

Elanco

While consumer demand for milk and dairy products continues to rise globally, dairy producers worldwide face significant challenges.

According to Elanco, increasing accessibility and affordability of dairy products hinges on healthy and productive cows

The World Organization for Animal Health reports 20% of livestock productivity is lost to death and disease annually, impacting global food security and producer profitability.  

Elanco has said that this acquisition allows the company to offer more proactive nutritional health interventions that can be tailored to the individual health of each cow to meet their health and disease prevention needs when they are most susceptible.

The company added that by combining Elanco's scientific rigour, technical teams and strong distribution experience, these have the potential to become essential tools for the dairy industry.

Ultimately Elanco claims this will lead to improved animal well-being further reducing the need for antibiotics on farms.